Welcome : Guest

RPG Life Sciences Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about RPG Life Sciences Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 139 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-25518
Price: $3500
Company Type: Public
Pages: 147
Date: January 2017
Market Data Tables: 139

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: RPG Life Sciences Ltd.'s (Operations) Sales by Product Segment Worldwide (2016) in Percentage for Pharmaceutical Preparations (Tablets, Liquids, Injections - Ampoules, and Capsules), Bulk Drugs and Chemicals, Product Development, and Other Operating Revenue......9
Table 2: RPG Life Sciences Ltd.'s (Operations) Sales by Geographic Region Worldwide (2015-2016) in Percentage for India, and Others Countries......10
Table 3: RPG Life Sciences Ltd.'s Sales by Country Worldwide (2014-2015) in Percentage for India and Others Countries......11
Drugs......12
Table 4: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......12
Active Pharmaceutical Ingredients (API)......13
Table 5: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......13
Table 6: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......14
Table 7: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......15
Table 8: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......16
Table 9: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......17
Anticholinergic Agents......18
Table 10: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......18
Cardiology Therapeutics......19
Table 11: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......19
Table 12: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......20
Table 13: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......21
Anti-Thrombotic......22
Table 14: Anti-Thrombotic Sales by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Clopidogrel, Dabigatran, Lovenox, Prasugrel, Rivaroxaban, Ticagrelor, and Autres......22
Antispasmodics......23
Table 15: Antispasmodics Market by Business Segment in the US (2015) - Percentage Share Breakdown by Value for Branded, and Generics......23
Central Nervous System (CNS) Drugs......24
Table 16: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......24
Table 17: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......25
Anti-Psychotics......26
Table 18: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......26
Table 19: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......27
Cancer Drugs......28
Table 20: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......28
Table 21: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......29
Cancer Market......30
Table 22: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......30
Table 23: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......31
Table 24: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......32
Table 25: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......33
Table 26: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......34
Table 27: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......35
Table 28: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......36
Table 29: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......37
Cancer Patients......38
Table 30: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......38
Table 31: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......39
Table 32: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......40
Table 33: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......41
Table 34: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......42
Table 35: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......43
Table 36: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......44
Table 37: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......45
Table 38: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......46
Table 39: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......47
Table 40: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......48
Table 41: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......49
Table 42: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......50
Table 43: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......51
Table 44: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......52
Table 45: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......53
Table 46: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......54
Table 47: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......55
Table 48: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......56
Table 49: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......57
Table 50: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......58
Cervical Cancer......59
Table 51: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......59
Table 52: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......60
Hematological Cancer......61
Table 53: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......61
Skin Cancer......62
Table 54: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......62
Cancer-Associated Mucositis......63
Table 55: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......63
Chronic Myelogenous Leukemia (CML)......64
Table 56: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......64
Multiple Myeloma......65
Table 57: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......65
Table 58: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......66
Gastrointestinal Drugs......67
Table 59: Gastrointestinal Market Worldwide (2015) in US$ Million......67
Table 60: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......68
Pain Drugs......69
Table 61: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......69
Antiplatelets......70
Table 62: Antiplatelet Sales by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Clopidogrel, Dipyridamole and Others......70
Pulmonary Arterial Hypertension (PAH)......71
Table 63: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......71
Table 64: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......72
Table 65: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......73
Table 66: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......74
Table 67: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......75
Table 68: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......76
Table 69: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......77
Table 70: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......78
Table 71: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......79
Table 72: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......80
Vitamins and Dietary Supplements......81
Table 73: Vitamins and Supplements Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for China, European Union, Japan, USA and Others......81
Table 74: Vitamins and Supplements Retail Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Dietary Supplements, Paediatric Vitamins and Supplements, Tonics and Nutritive, and Vitamins......82
Table 75: Vitamins Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for A, B, C, E, and Others......83
Table 76: Vitamins Sales by Category Worldwide (2015) - Percentage Share Breakdown by Value for Animal, and Human......84
Table 77: Vitamins and Dietary Supplements (VDS) Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......85
Table 78: Vitamin and Supplements Market by Channel in the US (2015) - Percentage Breakdown by Value for Mass Marketers, Specialty Retailers, and Others......86
Table 79: Vitamins Sales by Category through Supermarkets, Drug Stores and Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) - Percentage Share Breakdown by Value for Adult Multivitamins, Calcium, Children's Multivitamins, Vitamin B, Vitamin C, Vitamins A&D, and Others......87
Table 80: Vitamins Sales through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Dollar and Club Chains by Sector in the US (2015) - Percentage Share Breakdown by Value for 1 & 2 Letter, Liquid Vitamins & Minerals, Mineral Supplements, and Multivitamins......88
Chronic Kidney Disease......89
Table 81: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......89
Table 82: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......90
Table 83: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......91
Dialysis......92
Table 84: Dialysis Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Dialysis Care, Dialysis Products......92
Table 85: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......93
Table 86: Dialysis Product Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hemodialysis Products, and Peritoneal Dialysis Products......94
Table 87: No. of Dialysis Patients by Category in China (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, and Peritoneal Dialysis Patients......95
Table 88: No. of Dialysis Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, Peritoneal Dialysis Patients, and Transplant patients......96
Table 89: No. of Dialysis Patients by Geographic Region Worldwide (2015) - Percentage Share Breakdown for Europe, Japan, Rest of World (RoW), and USA......97
Dialysis Patients......98
Table 90: No. of Dialysis Patients by Region Worldwide (2015) - Percentage Market Share Breakdown by Volume for Asia-Pacific, Europe, the Middle East and Africa (EMEA), Latin America, and North America......98
Table 91: No. of Dialysis Patients by Treatment Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Hemodialysis, and Peritoneal Dialysis......99
Peritoneal Dialysis......100
Table 92: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......100
Hemodialysis......101
Table 93: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......101
Cardiology Therapeutics......102
Table 94: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......102
Antipsychotics......103
Table 95: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......103
Table 96: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......104
Table 97: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......105
Table 98: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......106
Central Nervous System (CNS) Medicines......107
Table 99: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......107
Table 100: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......108
Cancer Drugs......109
Table 101: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......109
Table 102: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......110
Table 103: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......111
Table 104: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......112
Table 105: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......113
Breast Cancer Drugs......114
Table 106: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......114
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......115
Table 107: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......115
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......116
Table 108: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......116
Table 109: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Other......117
Gastrointestinal Drugs......118
Table 110: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......118
Table 111: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......119
Table 112: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......120
Table 113: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......121
Table 114: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......122
Pain Management Drugs......123
Table 115: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......123
Table 116: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......124
Table 117: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......125
Table 118: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......126
Table 119: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Other......127
Table 120: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......128
Anti-Infectives......129
Table 121: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Other......129
Vitamins......130
Table 122: Market Shares of Leading Vitamins Producers Worldwide (2015) - Percentage Share Breakdown by Value for Adisseo, BASF, DSM and Others......130
Table 123: Market Shares of Leading Vitamins Suppliers Worldwide (2015) - Percentage Breakdown by Value for Adisseo, BASF SE, Koninklijke DSM N.V., and Others......131
Table 124: Market Shares of Leading Vitamin Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Reckitt Benckiser Group plc, and Others......132
Table 125: Market Shares of Leading Vitamins Producers in the US (2015) - Percentage Share Breakdown by Value for Church & Dwight Co., Inc., and Others......133
Table 126: Market Shares of Leading Vitamin and Supplement Retailers in the US (2015) - Percentage Breakdown by Value for General Nutrition Centers, Inc., The Vitamin Shoppe, Whole Foods Market IP. L.P., and Others......134
Table 127: Market Shares of Leading Vitamins & Dietary Supplement Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Procter & Gamble Co., Private Label and Others......135
Vitamins (1 & 2 Letter)......136
Table 128: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Church & Dwight Co. Inc., NBTY, Inc., Pharmavite, LLC, Rexall Sundown, Inc., Private Label, and Others......136
Table 129: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for NBTY, Inc., Pharmative, LLC, Rexall Sundown, Inc., Private Label, and Others......137
Table 130: Market Shares of Leading Vitamin (1 & 2 Letter) Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Church & Dwight Co. Inc., NBTY, Inc., Pharmavite, LLC, Rexall Sundown, Inc., Private Label, and Others......138
Table 131: Market Shares of Leading Vitamin (1 & 2 Letter) Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Nature Made, Nature’s Bounty, Sundown Naturals, Private Label, and Others......139
Adult Gummy Vitamins......140
Table 132: Market Shares of Leading Adult Gummy Vitamin Brands through Food Stores, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for One-A-Day(Bayer), Vitafusion, Private Label, and Others......140
Liquid Vitamins......141
Table 133: Market Shares of Leading Liquid Vitamin & Mineral Brands Through Drug Store in the US (2015) - Percentage Breakdown by Value for Alacer Emergen-C, Emergen-C, Joint Juice, Private Label, and Others......141
Table 134: Market Shares of Leading Liquid Vitamin & Mineral Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Alacer Corporation, Mead Johnson & Co., LLC, Neurobrands, LLC, Premier Nutrition Corporation, Private Label, and Others......142
Table 135: Market Shares of Leading Liquid Vitamin/Mineral Manufacturers through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Alacer Corporation, Mead Johnson & Co., LLC, Neurobrands, LLC, Private Label, and Others......143
Multivitamins......144
Table 136: Market Shares of Leading Multivitamin Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Airborne, Centrum, Centrum Silver, Flintstones, Private Label, and Others......144
Table 137: Market Shares of Leading Multivitamin Brands through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart) Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Airborne, Bausch and Lomb PreserVision, Centrum Silver, One A Day VitaCraves, Private Label, and Others......145
Table 138: Market Shares of Leading Multivitamin Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Airborne (Reckitt Benckiser Group plc), Bausch & Lomb Inc., Bayer AG, Church & Dwight Co., Inc., Nature’s Way Products, LLC, Pfizer, Inc., Private Label, and Others......146
Dialysis......147
Table 139: Market Shares of Leading Dialysis Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA, DaVita Healthcare Partners, Inc. and Others......147